Sign Up to like & get
recommendations!
0
Published in 2024 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-024-00914-1
Abstract: ABP 938 is being developed as a biosimilar candidate to aflibercept reference product (RP), a biologic used for certain angiogenic eye disorders. This study was designed to provide a comparative analytical assessment of the structural…
read more here.
Keywords:
reference;
938 aflibercept;
reference product;
aflibercept reference ... See more keywords